Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by BlueJays9293on Feb 15, 2024 11:12pm
205 Views
Post# 35883454

RE:RE:RE:RE:RE:RE:RE:RE:And The Final Numbers On Volume

RE:RE:RE:RE:RE:RE:RE:RE:And The Final Numbers On Volume Most interesting thing I saw in the Paradigm update is that they expect "Baxter to make a quick decision," and that they expect, "a joint announcement in the coming weeks."

What "coming weeks" means is for each of you to decide but for me, I just see it as another sign of things moving quickly and happening with a sense of urgency going into this July Vantive/Baxter Spinoff.

And the reason this July Vantive/Baxter spinoff is so at the forefront of my mind started with the simple "sizzle" theory as MM likes to call it, and then after my research it has grown and led me to believe that yes, that smoke really looks like it leads to a big fire.

My Vantive research was at first just going thru Baxter's latest earning conference call transcript and then I looked at one of the ratings agencies named Fitch that put out their assesment of Baxter and Vantive in a Bond rating type way that they do as opposed to a typical stock analyst type way.  And there are definitely some interesting Easter Eggs in that Bond rating report.  I'll leave the link to the Fitch report at the end but I'm going to leave it up to you to see the things that perked my attention.

But that aside, I did get some great satisfaction out of today's news releases as well.

All of us old timers know that January was nothing short of great in terms of enrollment.

But all of us old timers were also really wondering in the back of our minds, if it would last, after so many months and years even of not just slow enrollment but almost stagnant enrollment.

Today proved to me that they have finally figured something out with the pace of enrollment, and that with 3 now in February, that yes it can last.

Here's the Fitch analyst report on Baxter/Vantive for those interested.

https://www.fitchratings.com/research/corporate-finance/fitch-downgrades-baxter-ratings-to-bbb-outlook-stable-04-01-20244


<< Previous
Bullboard Posts
Next >>